Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer.
about
Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Expression of ERCC1, Bcl-2, Li ...... mas or small cell lung cancer.
@en
type
label
Expression of ERCC1, Bcl-2, Li ...... mas or small cell lung cancer.
@en
prefLabel
Expression of ERCC1, Bcl-2, Li ...... mas or small cell lung cancer.
@en
P2093
P2860
P356
P1476
Expression of ERCC1, Bcl-2, Li ...... mas or small cell lung cancer.
@en
P2093
Breno Galvão
Duilio Rocha Filho
Frederico Perego Costa
Gilberto de Castro
João Evangelista Bezerra Neto
Juliana Florinda de M Rêgo
Juliana Guerra
Lidia Kimura
Maria Ignez Braghiroli
Paulo Marcelo Hoff
P2860
P356
10.3332/ECANCER.2017.767
P577
2017-09-11T00:00:00Z